ASCO 2021 Annual Meeting

PSMA-targeted 18F-DCFPyL-PET/CT May Impact Staging in Prostate Cancer

The use of PSMA-targeted 18F-DCFPyL-PET/CT may provide specific staging information in patients with prostate cancer recurrence or metastases on conventional imaging, according to a study. The...

Curated Journal reading List

Advertisement
Advertisement

Expert Interviews